Subsequently, leveraging network pharmacology predictions, in vivo experiments were performed to further elucidate the nephroprotective mechanisms of SIN, primarily through the suppression of the cGAS/STING signaling pathway and its associated inflammatory response in db/db mice. The gene discussed is STING1; the disease is squamous cell intraepithelial neoplasia.